Financial Performance - For the three months ended September 30, 2023, the company reported a net loss of 104,535,resultingfromoperatingandformationcostsof282,917, franchise tax expense of 40,444,andincometaxexpenseof47,418, partially offset by interest and dividend income of 266,244[125].−FortheninemonthsendedSeptember30,2023,thecompanyhadanetincomeof705,584, primarily from interest and dividend income of 2,367,607,offsetbytotalexpensesof1,661,023 [126]. - For the nine months ended September 30, 2023, the Company reported a loss from operations of 1,185,182andnetcashusedinoperatingactivitiesof1,715,587 [138]. - The company incurred total expenses of 1,088,247fortheninemonthsendedSeptember30,2023,primarilyduetooperatingandformationcosts[126].CashandTrustAccount−AsofSeptember30,2023,thecompanyhadapproximately20 million remaining in the trust account after stockholders redeemed 9,577,250 shares of Class A common stock [119]. - As of September 30, 2023, the Company had 574,336incashheldoutsideoftheTrustAccountandaworkingcapitaldeficitof643,843 [138]. - For the nine months ended September 30, 2023, net cash used in operating activities was 1,715,587,withinterestanddividendsearnedonmarketablesecuritiesof2,367,607 [129]. Business Combination and Merger - The company entered into a merger agreement with SBC Medical Group Holdings Incorporated, with a total consideration of 1,000,000,000,subjecttoadjustmentsbasedonSBC′snetworkingcapitalandoutstandingindebtedness[117].−ThecompanyapprovedanextensiontoconsummateabusinesscombinationuntilFebruary9,2024,withoutadditionalpaymentfromthesponsor[119].−TheCompanyhasuntilFebruary9,2024,toconsummateabusinesscombination,oritwillfacemandatoryliquidationandpotentialdissolution[138].InitialPublicOffering(IPO)−Thecompanyraisedgrossproceedsof115,000,000 from its Initial Public Offering, with 117,875,000placedinatrustaccountforfuturebusinesscombinations[134][136].−Theunderwritersexercisedanover−allotmentoptiontopurchaseanadditional1,500,000Unitsatanofferingpriceof10.00 per Unit, totaling 15,000,000[143].−Acashunderwritingdiscountof1,955,000 was paid to the underwriters upon the closing of the Initial Public Offering [144]. - The Company has a promissory note from the Sponsor for up to 300,000tocoverInitialPublicOfferingexpenses,whichwasfullyrepaidattheclosingoftheInitialPublicOffering[145].CostsandExpenses−TheCompanyhasincurredsignificantcostsinpursuitoffinancingandacquisitionplans,andexpectstoneedadditionalcapitalbeyondthenetproceedsfromtheInitialPublicOffering[138].−TheCompanyincurred90,000 in administrative support fees for the nine months ended September 30, 2023, paid to Mehana Capital LLC [142]. Stock and Redemption - The Company recognizes changes in redemption value of Class A common stock immediately and adjusts the carrying value to equal the redemption value at the end of each reporting period [151]. - The calculated net income (loss) per share is the same for Class A and Class B common stock, with no consideration for the effect of Public and Placement Warrants in the calculation [152].